Federal Register Notice: FDA is requesting that any industry organizations interested in participating in the selection of a nonvoting industry representative to serve on CBER’s Blood Products Advisory Committee, notify FDA in writing. A nominee may either be self-nominated or nominated by an organization to serve as a nonvoting industry representative. Nominations will be accepted for an upcoming vacancy on 9/30. To view this notice, click here.
